The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Regulatory News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.53
Bid: 1.526
Ask: 1.60
Change: -0.037 (-2.36%)
Spread: 0.074 (4.849%)
Open: 1.53
High: 1.53
Low: 1.53
Prev. Close: 1.567
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

7 May 2020 13:59

RNS Number : 3131M
Hemogenyx Pharmaceuticals PLC
07 May 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

HEMOGENYX PHARMACEUTICALS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

CRAIG AURINGER

City and country of registered office (if applicable)

LONDON, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

07/05/2020

6. Date on which issuer notified (DD/MM/YYYY):

07/05/2020

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.04

 

6.04

397,253,969

 

Position of previous notification (if

applicable)

5.9

 

5.9

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYX3WZ24

23,987,250

 

6.04%

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

23,987,250

6.04%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

     

 

Place of completion

London

Date of completion

07/05/2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLBDGDULUGDGGR
Date   Source Headline
9th Mar 20212:00 pmRNSPrice Monitoring Extension
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSH.C. Wainwright Investment Conference
3rd Mar 20217:00 amRNSHEMO-CAR-T Update
26th Feb 202110:05 amRNSTotal Voting Rights
25th Feb 20214:56 pmRNSConversion of Convertible Loan Notes
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSAllotment of Shares
3rd Feb 20217:01 amRNSDraw Down Under Financing Facility Agreement
29th Jan 20212:24 pmRNSPublication of Prospectus
13th Jan 20217:00 amRNSUpdate on CDX Antibody Development
6th Jan 20213:53 pmRNSResult of General Meeting
5th Jan 20217:00 amRNSCAR-T Master Translational Agreement with Penn
8th Dec 20207:00 amRNSChange to Date of General Meeting
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPosting of Circular
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
18th Nov 20202:06 pmRNSSecond Price Monitoring Extn
18th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Nov 202010:39 amRNSFinancing Facility of up to £60 Million
27th Oct 20207:00 amRNSCDX Development Agreement Further Extension
19th Oct 20207:00 amRNSPresentation at the American Society of Hematology
6th Oct 20207:00 amRNSSAFE-HEMO-CAR-T Effective against AML in vitro
30th Sep 20207:00 amRNSInterim Results for the period ended 30 June 2020
22nd Sep 202012:52 pmRNSFurther re. Grant of Options
10th Sep 20204:40 pmRNSSecond Price Monitoring Extn
10th Sep 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20202:06 pmRNSSecond Price Monitoring Extn
26th Aug 20202:00 pmRNSPrice Monitoring Extension
25th Aug 20204:40 pmRNSSecond Price Monitoring Extn
25th Aug 20204:35 pmRNSPrice Monitoring Extension
21st Aug 20209:52 amRNSGrant of Options
14th Aug 20207:00 amRNSPresentations at Cancer Immunotherapy Symposia
11th Aug 20207:00 amRNSCAR-T Agreement with University of Pennsylvania
31st Jul 20207:00 amRNSBroker's Research Note
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 20202:05 pmRNSSecond Price Monitoring Extn
20th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20209:06 amRNSSecond Price Monitoring Extn
14th Jul 20209:00 amRNSPrice Monitoring Extension
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:16 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.